COUNTRY OF ORIGINSerodiagnosis KIT of Human Leptospirosis and Chagas Disease
Using the Leptospirosis and Chagas KIT in other countries
In general, technology is making rapid progress. This is particularly true in the developed world, but not in the case of developing countries where economic resources are few or even non existent. For this reason, the perfection of new biomedical technologies is vital for rapid progress and health improvement.
LEPTOSPIROSIS KIT
The innovative technology behind the leptospirosis KIT can be transferred to any health ministries in Latin American countries that want to effectively deal with the problem of Human Leptospirosis and create an early warning system for outbreaks. The KIT can be produced and applied directly by health ministries in any country, with no need for commercial intermediaries.
The PAHO/WHO, through their national and representative offices, can support the process of transferring the technology from Nicaragua.
Despite the fact that the technical and scientific bases of ELISA type assays date back to the 1980s, modifications and applicability are subject to restriction from international legislation as a result of commercialisation. Restrictions do not apply if the assays are applied locally and not produced for commercial ends.
The KIT for the serologic diagnosis of Human Leptospirosis is an innovative product that can be easily replicated in other Latin American countries with laboratories that have the capacity for diagnostic resolution and meet requirements of biosecurity.
THE CHAGAS KIT
Despite the fact the technical and scientific bases of ELISA type assays date back to the 1980s, modifications and applicability are subject to restriction from international legislation as a result of commercialisation. Restrictions do not apply if the assays are applied locally and not produced for commercial ends.
The innovative technology behind the KIT can be transferred to any health ministries in Latin American countries that want to effectively deal with the problem of Chagas Disease. The KIT can be produced and applied directly by health ministries in any country, with no need for commercial intermediaries.
The CNDR/MINSA Chagas KIT is a finished product which can be easily replicated in other Latin American countries that have laboratories meeting diagnostic resolution standards.
